Our study assessed the impact of PAK4 expression in surgically treated RCC and found a significant association with PFS in CCRCC, although PAK4 was not identified as a top-ranked gene in this context by Linehan et al. [55]. The gene discussed is PAK4; the disease is nonpapillary renal cell carcinoma.